Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting
Luca Navarini, Luisa Costa, Marco Tasso, Maria Sole Chimenti, Damiano Currado, Giulia Lavinia Fonti, Massimo Ciccozzi, Domenico Paolo Emanuele Margiotta, Carolina Benigno, Erica De Martino, Roberto Perricone, Antonella Afeltra, Raffaele Scarpa, Francesco Caso
Topics & Concepts
MedicineDiscontinuationPsoriatic arthritisInternal medicineRetention rateProportional hazards modelAdverse effectUstekinumabRetrospective cohort studyRheumatoid arthritisTNF inhibitorRheumatologyEtanerceptAdalimumabComputer scienceComputer securitySpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and Pathogenesis